LNCD(SH:600739)2022-04-29 16:00Financial Performance - The company's operating revenue for Q1 2022 was CNY 3,559,219,794.43, representing a decrease of 10.38% compared to the same period last year[2]. - The net profit attributable to shareholders was CNY 276,186,210.05, down 48.29% year-on-year[2]. - The diluted earnings per share was CNY 0.1805, reflecting a decline of 48.31% compared to the previous year[3]. - The weighted average return on equity decreased by 1.22 percentage points to 0.98%[3]. - The total profit margin for Q1 2022 was approximately 7.5%, down from 9.4% in Q1 2021, indicating a decline in profitability[18]. - The net profit for Q1 2022 was approximately ¥502.05 million, a decrease of 26.4% compared to ¥682.47 million in Q1 2021[18]. - The total comprehensive income for Q1 2022 was approximately ¥436.64 million, down from ¥609.03 million in Q1 2021, reflecting a decline of 28.3%[18]. - The company reported a total comprehensive income of -11,712,925.72 CNY for Q1 2022, compared to 217,379,626.35 CNY in Q1 2021[25]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 47,972,020,558.45, a slight decrease of 0.10% from the end of the previous year[3]. - Total assets as of Q1 2022 amounted to ¥47,972,020,558.45, slightly down from ¥48,017,838,715.58 in the previous quarter[15]. - Total liabilities for Q1 2022 were ¥16,058,219,255.82, a decrease from ¥16,540,676,515.15 in the previous quarter[15]. - Total liabilities amounted to CNY 14.16 billion, down from CNY 14.78 billion, a decrease of approximately 4.2%[22]. - Non-current liabilities totaled ¥2,214,724,830.32, down from ¥2,913,963,641.28 in the previous quarter[15]. - Non-current liabilities decreased to CNY 1.83 billion from CNY 2.53 billion, a decline of about 27.6%[22]. Cash Flow - The net cash flow from operating activities was CNY 238,371,121.05, with no applicable year-on-year comparison[2]. - Cash inflow from operating activities in Q1 2022 was approximately ¥3.89 billion, an increase of 23.1% from ¥3.16 billion in Q1 2021[19]. - The net cash flow from operating activities for Q1 2022 was 426,816,658.94 CNY, a significant improvement from a negative cash flow of -94,670,412.26 CNY in Q1 2021[27]. - The cash and cash equivalents at the end of Q1 2022 were approximately ¥4.40 billion, down from ¥2.45 billion at the end of Q1 2021, indicating a decrease in liquidity[20]. - The total cash outflow from financing activities in Q1 2022 was 4,722,010,579.08 CNY, compared to 2,966,622,274.63 CNY in Q1 2021, indicating a 59.1% increase[27]. Shareholder Information - Total number of common shareholders at the end of the reporting period was 74,537[8]. - The largest shareholder, Shaoguan Gaoteng Enterprise Management Co., Ltd., holds 234,004,700 shares, accounting for 15.30% of total shares[8]. - The second largest shareholder, Liaoning State-owned Assets Management Co., Ltd., holds 169,889,039 shares, representing 11.11% of total shares[8]. - The total number of shares held by the top ten shareholders is significant, with the top three holding over 34% of the total shares[11]. - The company has not engaged in margin financing or securities lending activities among its top ten shareholders[11]. Expenses and Investments - The company reported a significant increase in prepaid expenses by 39.63% due to the impact of commodity business cycles[6]. - Tax payable increased by 335.84%, primarily due to increased exports of epidemic prevention materials[6]. - Investment income decreased by 51.78%, attributed to a decline in investment income from joint ventures[7]. - The company experienced a 31.12% increase in selling expenses, mainly due to higher export commissions related to epidemic prevention materials[7]. - Research and development expenses for Q1 2022 were ¥47,298,376.40, down from ¥64,259,108.26 in Q1 2021[17]. - Financial expenses increased to CNY 90.78 million from CNY 79.32 million, marking an increase of approximately 14.8%[24]. - Investment income fell to CNY 176.28 million from CNY 396.18 million, a decrease of about 55.6%[24]. Inventory and Cash Equivalents - Cash and cash equivalents decreased to 4,568,126,467.79 RMB from 5,597,021,396.39 RMB at the end of 2021[13]. - Inventory increased to 2,175,233,029.17 RMB from 2,019,646,009.99 RMB at the end of 2021[13]. - The cash and cash equivalents at the end of Q1 2022 were 1,712,915,636.66 CNY, slightly down from 1,773,700,324.05 CNY at the end of Q1 2021[27]. Other Information - The company did not report any new product launches or significant market expansion strategies during the conference call[28].